Use of aryl oximes for the prophylaxis and/or treatment of erythema formation and/or inflammatory reaction of the skin

Abstract

The present invention relates to the use of at least one aryl oxime of Formula (I). 1 wherein: Y, Z represent independently from each other H, C1-18 alkyl, C2-18 alkenyl, C2-18 carboxy alkyl, C3-18 carboxy alkenyl or C2-18 alkanoyl; R represents C1-18 alkyl, C2-18 alkenyl, C3-8 cycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl or condensed systems; R1, R2, R3 and R4 represent independently from each other H, C1-12 alkyl, C2-12 alkenyl, C1-12 alkoxy, C3-8 cycloalkoxy, aryl, aryloxy, aralkyl, heteroaryl, heteroaralkyl, carboxy, hydroxy, chlorine, dialkyl amine or sulfonyl, for the prophylaxis and/or treatment of erythema formation and/or inflammation responses of the skin.

Dependencies are inferred from the claim text.